UPPTHERA
@uppthera.com
UPPTHERA, Inc. is a pharmaceutical venture company aiming for new drug development employing 'targeted protein degradation' technology.
UPPTHERA's Company Logos
UPPTHERA's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#2EA7E0
Curious Blue
46, 167, 224
199, 74, 53
79, 25, 0, 12
#73BFD5
Downy
115, 191, 213
193, 54, 64
46, 10, 0, 16
#413A4A
Ship Gray
65, 58, 74
266, 12, 26
12, 22, 0, 71
About UPPTHERA
Uppthera, also known as 업테라, is a pharmaceutical venture company dedicated to new drug development using targeted protein degradation technology. At Uppthera, our mission is to bridge the gap between patients suffering from undruggable diseases and the hope for a cure. Our team of experienced leaders, including CEO/Co-Founder SiWoo Choi, CDO/Co-Founder SooHee Ryu, CSO/Co-Founder JiHoon Ryu, COO/Co-Founder HwaJin Lee, CBO/Co-Founder SanHa Son, and CCO HeungSik Hamh, brings together a wealth of expertise in biotechnology, life science, and technology management.
With our innovative and novel E3 ligase Platform, known as the UPPGRADER™ Platform, we aim to revolutionize targeted protein degradation. This platform allows us to harness the power of autophagy and proteasomal degradation pathways to selectively remove disease-causing proteins from the body, offering new possibilities for therapeutic intervention. If you're interested in a career at Uppthera, we offer a collaborative and dynamic work environment, with job openings available.
Contact us to learn more about our company or to explore partnership opportunities. Visit our website for more information about our products, services, and research
Company type
Privately Held
Year founded
2018
Company size
51-200 employees
